Hermansky-Pudlak Syndrome: From Molecular Pathogenesis to Targeted Therapies
Francesca Tondi1, Roberta Annamaria Cirsmaru2, Chiara Conti1
1Department of Medicine and Surgery, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.
IUBMB Life
|May 19, 2025
Summary
Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder affecting lysosome-related organelles. Research highlights its genetics, clinical features, and limited treatments, emphasizing the need for innovative therapies.
Area of Science:
- Genetics and Molecular Biology
- Cell Biology
- Rare Diseases
Background:
- Hermansky-Pudlak syndrome (HPS) is a rare inherited disorder impacting lysosome-related organelles (LROs) in multiple cell types.
- Clinical manifestations include oculocutaneous albinism, bleeding disorders, and potentially pulmonary fibrosis, granulomatous colitis, and immunodeficiency.
- Mutations in 11 genes essential for LRO biogenesis underlie HPS.
Purpose of the Study:
- To review the current understanding of Hermansky-Pudlak syndrome (HPS) genetics and molecular mechanisms.
- To discuss the clinical spectrum and existing therapeutic strategies for HPS.
- To identify knowledge gaps and emphasize the need for novel treatment development.
Main Methods:
- Literature review focusing on genetics, molecular mechanisms, clinical manifestations, and therapies for HPS.
- Analysis of current research on cell and gene therapy applications.
- Exploration of induced pluripotent stem cell (iPSC) models for disease insight.
Main Results:
- HPS is linked to mutations in 11 genes critical for lysosome-related organelle formation.
- Current treatments for HPS are limited and often lack efficacy.
- Limited data exists on cell and gene therapy applications for HPS in platelets and endothelial cells.
Conclusions:
- A comprehensive understanding of HPS pathogenesis is essential for developing effective treatments.
- Induced pluripotent stem cell (iPSC) models offer a promising avenue for studying HPS molecular processes.
- Further research is crucial to advance therapeutic strategies for Hermansky-Pudlak syndrome.
Related Concept Videos
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
342
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
342
01:22Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
01:19X-linked Traits
52.6K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
52.6K
01:30Peptic Ulcer Disease I: Introduction
114
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
114